These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 5097217)
1. [Results and prospects of the use of drugs acting on serum lipoproteins in atherosclerosis]. Fasoli A Minerva Med; 1971 Sep; 62(72):3458-65. PubMed ID: 5097217 [No Abstract] [Full Text] [Related]
2. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)]. Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781 [No Abstract] [Full Text] [Related]
3. The influence of drugs affecting lipids on atherosclerosis. Ditschuneit H Horm Metab Res; 1974; Suppl 4():191-4. PubMed ID: 4421312 [No Abstract] [Full Text] [Related]
4. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation; 1984 May; 69(5):1067A-1090A. PubMed ID: 6368042 [No Abstract] [Full Text] [Related]
5. [Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis]. Mazzei ES; Mazzei CM; Gotelli C Prensa Med Argent; 1967 Mar; 54(5):199-203. PubMed ID: 5605172 [No Abstract] [Full Text] [Related]
6. [New aspects of the therapy of arteriosclerosis]. Avogaro P; Capri C; Cazzolato G Recenti Prog Med; 1971 Nov; 51(5):455-70. PubMed ID: 5172398 [No Abstract] [Full Text] [Related]
12. A one year double blind study of the effect of halofenate and clofibrate in patients with hyperlipoproteinemia. Rottiers R; van Egmond J Acta Clin Belg; 1975; 30(5):398-408. PubMed ID: 1221746 [No Abstract] [Full Text] [Related]
13. [Clinical evaluation of the antidyslipemic action of a sulfomucopolysaccharide of pancreatic origin]. Svetoni N; D'Alonzo D; Rechichi A Clin Ter; 1974 Oct; 71(1):33-48. PubMed ID: 4279159 [No Abstract] [Full Text] [Related]
14. [Clinical evaluation of antiarteriosclerotic drugs in current use]. Piro S Recenti Prog Med; 1972 Apr; 52(4):386-9. PubMed ID: 5068415 [No Abstract] [Full Text] [Related]
15. [Recent concepts of arteriosclerosis, studied in correlation with the classification of hyperlipoproteinemia and the indicated laboratory methods]. Malcolm J; Lockwood P; Hunt P; Thomas B Brux Med; 1973 Mar; 53(3):179-87. PubMed ID: 4721664 [No Abstract] [Full Text] [Related]
16. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini]. Kritchevsky D Minerva Med; 1979 Dec; 70(55):3808-9. PubMed ID: 523009 [No Abstract] [Full Text] [Related]
17. Effects of Xiaoyu tablet on blood lipid and lipoproteins in hyperlipidemic rabbits with atherosclerosis. Xie ML; Gu ZL; Zhu LJ Chin Med J (Engl); 2005 Oct; 118(19):1651-3. PubMed ID: 16232351 [No Abstract] [Full Text] [Related]
18. [Drugs which decrease serum lipids]. Oye I Tidsskr Nor Laegeforen; 1973 Jan; 93(1):32-3. PubMed ID: 4691222 [No Abstract] [Full Text] [Related]
20. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related] [Next] [New Search]